PRF Technologies Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PRFX research report →
Companyprf-tech.com
PRF Technologies Ltd. , a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia.
- CEO
- Efraim Cohen-Arazi
- IPO
- 2020
- Employees
- 2
- HQ
- Tel Aviv, IL
Price Chart
Valuation
- Market Cap
- $129.66K
- P/E
- -0.04
- P/S
- 0.00
- P/B
- 0.02
- EV/EBITDA
- 0.97
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -46.98%
- ROIC
- -33.93%
Growth & Income
- Revenue
- $17.00K · 0.00%
- Net Income
- $-4,838,000 · 66.84%
- EPS
- $-7.47 · 99.07%
- Op Income
- $-4,987,000
- FCF YoY
- 68.68%
Performance & Tape
- 52W High
- $17.95
- 52W Low
- $1.41
- 50D MA
- $2.23
- 200D MA
- $4.54
- Beta
- 0.77
- Avg Volume
- 517.66K
Get TickerSpark's AI analysis on PRFX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | Aviel Sigal | other | 43 |
| Mar 18, 26 | Aviel Sigal | other | 104 |
| Mar 18, 26 | Aviel Sigal | other | 612 |
| Mar 18, 26 | Aviel Sigal | other | 3,000 |
| Mar 18, 26 | BARON ELLEN S | other | 50 |
| Mar 18, 26 | BARON ELLEN S | other | 183 |
| Mar 18, 26 | Cohen-Arazi Efraim | other | 50 |
| Mar 18, 26 | Cohen-Arazi Efraim | other | 150 |
| Mar 18, 26 | Cohen-Arazi Efraim | other | 183 |
| Mar 18, 26 | Cohen-Arazi Efraim | other | 3,000 |
Our PRFX Coverage
We haven't published any research on PRFX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PRFX Report →